Trials / Completed
CompletedNCT01651858
Nurigra Chewable Tablet in Healthy Adult Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate pharmacokinetics of sildenafil citrate in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nurigra Chewable tablet | 1 tablet of 100mg, once a day |
Timeline
- Start date
- 2012-02-01
- Completion
- 2012-03-01
- First posted
- 2012-07-27
- Last updated
- 2012-07-27
Source: ClinicalTrials.gov record NCT01651858. Inclusion in this directory is not an endorsement.